CYRX_OUT_1 [2025-03-24 10:34:20 -0400] 1971 Bytes | 586 tokens | Cum: 586 tkns (7.32% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 10:34:18 AM on Mon Mar 24, 2025 -0400, and I'm firing up the spotlight on CryoPort (CYRX), moving from 5.69 to 6.81. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

Here's the first list of news for CryoPort:

C1 - Mar-18-25 07:59PM - Is Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds?
C2 - Mar-13-25 07:28AM - CryoPort (CYRX) Surges 5.9%: Is This an Indication of Further Gains?
C3 - Mar-12-25 08:30AM - Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories
C4 - Mar-05-25 02:10AM - CryoPort Inc (CYRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
C5 - Mar-04-25 05:35PM - CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
C6 - Mar-04-25 05:35PM 04:10PM - Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results
C7 - Mar-03-25 07:18AM - CryoPort Inc (CYRX) Q4 2024: Everything You Need To Know Ahead Of Earnings
C8 - Feb-18-25 08:30AM - Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on CryoPort (CYRX)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

CYRX_OUT_3 [2025-03-24 10:34:29 -0400] 1038 Bytes | 268 tokens | Cum: 856 tkns (10.70% of 8k)
==========================================================================

Showing C4 (chunk 1 of 4): C4:
**CryoPort Inc (CYRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges**
Date: Mar-05-25 02:10AM
Source: (GuruFocus.com)
URL: https://finance.yahoo.com/news/cryoport-inc-cyrx-q4-2024-071058422.html

For the complete transcript of the earnings call, please refer to thefull earnings call transcript.

CryoPort Inc (NASDAQ:CYRX) achieved total annual revenues of $228.4 million in 2024, aligning with expectations.

The life sciences service business experienced double-digit year-over-year growth, with bio storage and bioservices showing significant expansion.

Revenue from commercial cell and gene therapies increased by 37% in Q4 and 20% for the full year.

CryoPort Inc (NASDAQ:CYRX) supported a record number of 701 clinical trials, indicating potential commercial revenue opportunities.

The company improved its gross margin to 45.8% in Q4 2024, up from 40.6%

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CYRX_OUT_5 [2025-03-24 10:34:31 -0400] 933 Bytes | 302 tokens | Cum: 1275 tkns (15.94% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-24T12:23:43Z - Here are Monday's biggest analyst calls: Nvidia, Apple, IBM, Microsoft, Boeing, Netflix, Nucor, & mo...
A2 - 2025-03-20T02:15:58Z - Insider Selling: Cryoport, Inc. (NASDAQ:CYRX) CEO Sells 4,620 Shares of Stock...
A3 - 2025-03-20T02:16:00Z - Insider Selling: Cryoport, Inc. (NASDAQ:CYRX) CFO Sells 1,659 Shares of Stock...
A4 - 2025-03-19T10:20:18Z - Cryoport, Inc. (NASDAQ:CYRX) CFO Robert Stefanovich Sells 1,659 Shares...
A5 - 2025-03-18T23:59:22Z - Is Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds?...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CYRX_OUT_7 [2025-03-24 10:34:32 -0400] 1039 Bytes | 274 tokens | Cum: 1551 tkns (19.39% of 8k)
==========================================================================

Showing A1 (chunk 1 of 10): A1:
**Here are Monday's biggest analyst calls: Nvidia, Apple, IBM, Microsoft, Boeing, Netflix, Nucor, & more**Date: 2025-03-24Source: {'uri': 'cnbc.com', 'dataType': 'news', 'title': 'CNBC'}URL: https://www.cnbc.com/2025/03/24/biggest-wall-street-analyst-calls-monday-like-nvidia.htmlHere are the biggest calls on Wall Street on Monday: Melius reiterates Nvidia as buy The firm says Nvidia is "defensive." "The clouds over the AI semis space mentioned above are winning this year despite Nvidia having tailwinds from inferencing and a clear line of sight on hyperscaler orders through year-end." UBS upgrades CryoPort to buy from neutral UBS says the cell and gene therapy company is well positioned. 'We're upgrading CryoPort (CYRX) to Buy with a view that scaling cell and gene therapy service offerings provide a credible pathway to low-double-digit+ (~10%+) mid long term sales growth and positiv

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CYRX_OUT_9 [2025-03-24 10:34:34 -0400] 1039 Bytes | 232 tokens | Cum: 1785 tkns (22.31% of 8k)
==========================================================================

Showing A1 (chunk 2 of 10): e free cash flow." Evercore ISI downgrades Lennar to in line from outperform "Lennar is resolute in maintaining pace and letting margins be the shock absorber, and some day its "machine" could become a compelling differentiator for the company. However, in the meantime, there are real questions as to whether this machine is built for too much volume than the market will allow." Wedbush adds IBM to the best ideas list The firm says it's getting more constructive on shares of IBM. "We are now adding IBM to the Wedbush Best Ideas List reflecting our incremental confidence in this name. In a nutshell, investors remain nervous about the AI spending trajectory in this backdrop yet to the contrary we see many enterprises accelerating their strategic paths for 2025 which is bullish for the software ecosystem." UBS upgrades Nucor to buy from neutral UBS said shares are compelling for the steel co

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CYRX_OUT_11 [2025-03-24 10:34:35 -0400] 967 Bytes | 297 tokens | Cum: 2084 tkns (26.05% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-10-22T12:30:00Z - Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
B2 - 2024-10-21T12:30:00Z - TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
B3 - 2024-09-25T12:30:00Z - SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
B4 - 2024-05-03T13:02:08Z - Coinbase Global To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Friday
B5 - 2024-05-03T12:01:02Z - Analyst Ratings For CryoPort
B6 - 2024-04-25T14:02:07Z - Earnings Preview: CryoPort, Inc. (CYRX) Q1 Earnings Expected to Decline

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CYRX_OUT_13 [2025-03-24 10:34:41 -0400] 1039 Bytes | 280 tokens | Cum: 2366 tkns (29.58% of 8k)
==========================================================================

Showing B4 (chunk 1 of 2): B4:
**Coinbase Global To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Friday**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/05/38613204/coinbase-global-to-rally-around-22-here-are-10-top-analyst-forecasts-for-fridayTop Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Rosenblatt raised the price target for Apple Inc.  (NASDAQ:AAPL) from $189 to $196. Rosenblatt analyst Barton Crockett maintained a Neutral rating. Apple shares rose 2.2% to close at $173.03 on Thursday. See how other analysts view this stock.
Canaccord Genuity boosted the price target for Coinbase Global, Inc. (NASDAQ:COIN) from $240 to $280. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. Coinbase shares rose 8.9% to close at $228

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CYRX_OUT_15 [2025-03-24 10:34:43 -0400] 1094 Bytes | 275 tokens | Cum: 2743 tkns (34.29% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S8 - 2025-03-07 10-K ITEM 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper

The following discussion and analysis of our financial condition and results of our operations should be read in conjunction with our CONS financial statements and related notes...

S9 - 2025-03-04 8-K Item 2.02 Results of Oper and Fin Cond.

On March 4, 2025, Cryoport, Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2024. A copy of the press release issued by the Company is a...

S10 - 2024-11-07 10-Q e related unaudited condensed CONS statements of operations, comprehensive loss, and stockholders equity for the three and nine months ended September 30, 2024 and 2023, and cash flows for the three and nine months ended September 30, 2024 and 2023 and the related notes...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CYRX_OUT_17 [2025-03-24 10:34:44 -0400] 1038 Bytes | 225 tokens | Cum: 2970 tkns (37.12% of 8k)
==========================================================================

Showing S8 (chunk 1 of 6): S8:
ITEM 7. Managements Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of our operations should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this Form 10-K. Our actual results could differ materially from those contained in forward-looking statements due to a number of factors. See Forward-Looking Statements in this Form 10-K.

For further discussion and analysis regarding our financial condition and results of operations for the year ended December 31, 2023 as compared to the year ended December 31, 2022, refer to Part II, Item 7 - Managements Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC on March 13,

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CYRX_OUT_19 [2025-03-24 10:34:46 -0400] 1038 Bytes | 233 tokens | Cum: 3205 tkns (40.06% of 8k)
==========================================================================

Showing S8 (chunk 2 of 6): 2024.

General Overview

Cryoport is a leading global provider of innovative products and services supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Our mission is to enable the future of medicine for a new era of life sciences. With over 50 strategic locations covering the Americas, EMEA (Europe, the Middle East and Africa) and APAC (Asia Pacific), Cryoport's global platform provides mission-critical bio-logistics, bio-storage, bio-processing, and cryogenic systems to over 3,000 customers worldwide. Our platform of solutions and services, together with our global team of over 1,100 dedicated colleagues, delivers a unique combination of innovative supply chain technologies and services through our industry-leading brands, including Cryoport Systems, MVE Biological Solutions, CRYOPDP, and CRYOGENE.

See the Business section in Part I,

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

CYRX_OUT_21 [2025-03-24 10:35:04 -0400] 8221 Bytes | 2254 tokens | Cum: 5461 tkns (68.26% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+-------------------------+-----------------------+-----------------------+
| Volume: 378,445 | SMA50: -0.07% | Market Cap: 340.52M | Option/Short: Yes / Yes | Sales past 5Y: 63.51% | Sales Surprise: 1.76% |
+---------------------+-----------------------+------------------------+-------------------------+-----------------------+-----------------------+
| Avg Volume: 366.11K | SMA200: -11.65% | Shs Outstand: 49.91M | Short Float: 4.25% | Employees: 1186 | EPS Surprise: -43.44% |
+---------------------+-----------------------+------------------------+-------------------------+-----------------------+-----------------------+
| Rel Volume: 6.10 | Perf Week: 5.21% | Shs Float: 48.12M | Short Ratio: 5.59 | Debt/Eq: 0.62 | P/E: - |
+---------------------+-----------------------+------------------------+-------------------------+-----------------------+-----------------------+
| RSI (14): 54.24 | Perf Month: 9.69% | Inst Own: 95.73% | Short Interest: 2.05M | Sales Y/Y TTM: -2.09% | Earnings: Mar 04 AMC |
+---------------------+-----------------------+------------------------+-------------------------+-----------------------+-----------------------+
| ATR (14): 0.70 | Perf Quarter: -12.42% | Insider Own: 3.60% | Beta: 1.87 | ROE: -25.76% | |
+---------------------+-----------------------+------------------------+-------------------------+-----------------------+-----------------------+
| SMA20: 13.34% | Index: RUT | Insider Trans: -12.18% | Sales Q/Q: 3.97% | ROI: -19.42% | |
+---------------------+-----------------------+------------------------+-------------------------+-----------------------+-----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: Cryoport, Inc. (CYRX) by SHELTON JERRELL (President, CEO) on 2025-03-14
- Common Stock: 30000 shares at $0 (D)
- Common Stock: 4620 shares at $6.2917 (D) Footnote: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- Stock Option (right to buy): 75000 shares at $0 (D)

Inside Trans: Cryoport, Inc. (CYRX) by Sawicki Mark W (Chief Scientific Officer) on 2025-03-14
- Common Stock: 9000 shares at $0 (D)
- Common Stock: 2092 shares at $6.2917 (D) Footnote: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- Stock Option (right to buy): 24000 shares at $0 (D)

Inside Trans: Cryoport, Inc. (CYRX) by STEFANOVICH ROBERT (Chief Financial Officer) on 2025-03-14
- Common Stock: 10000 shares at $0 (D)
- Common Stock: 1659 shares at $6.2917 (D) Footnote: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- Stock Option (right to buy): 25000 shares at $0 (D)

Inside Trans: Cryoport, Inc. (CYRX) by ZECCHINI EDWARD J (Chief Digital and Tech Officer) on 2025-03-14
- Common Stock: 8000 shares at $0 (D)
- Common Stock: 1140 shares at $6.2917 (D) Footnote: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- Stock Option (right to buy): 20000 shares at $0 (D)

Inside Trans: Cryoport, Inc. (CYRX) by STEFANOVICH ROBERT (Chief Financial Officer) on 2025-03-09
- Common Stock: 2667 shares at $0 (D) Footnote: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
- Common Stock: 1256 shares at $4.8791 (D) Footnote: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- Restricted Stock Rights: 2667 shares at $0 (D) Footnote: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

Inside Trans: Cryoport, Inc. (CYRX) by SHELTON JERRELL (President, CEO) on 2025-03-09
- Common Stock: 8250 shares at $0 (D) Footnote: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
- Common Stock: 4173 shares at $4.8791 (D) Footnote: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- Restricted Stock Rights: 8250 shares at $0 (D) Footnote: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

Inside Trans: Cryoport, Inc. (CYRX) by Sawicki Mark W (Chief Scientific Officer) on 2025-03-09
- Common Stock: 2667 shares at $0 (D) Footnote: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
- Common Stock: 1583 shares at $4.8791 (D) Footnote: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- Restricted Stock Rights: 2667 shares at $0 (D) Footnote: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

[Company Financial Summary]
[Company Details]
Name: CryoPort, Inc. Common Stock
Market Cap: 281155952.86
Shares Outstanding: 49412294
Sector: PHARMACEUTICAL PREPARATIONS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 228385000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -114756000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 6.83
Average Volume: 596351.43
30-Day High: 7.04
30-Day Low: 4.7

[Detailed Financials: TTM 2024]
- Total Assets: $703,492,000.0
- Total Liabilities: $301,594,000.0
- Total Equity: $401,898,000.0
- Current Assets: $341,571,000.0
- Current Liabilities: $64,563,000.0

[Income Statement: TTM 2024]
- Revenue: $228,385,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -2.49

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-1,057,000.0

[Detailed Financials: FY 2024]
- Total Assets: $703,492,000.0
- Total Liabilities: $301,594,000.0
- Total Equity: $401,898,000.0
- Current Assets: $341,571,000.0
- Current Liabilities: $64,563,000.0

[Income Statement: FY 2024]
- Revenue: $228,385,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -2.49

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-1,057,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

CYRX_OUT_23 [2025-03-24 10:35:07 -0400] 676 Bytes | 167 tokens | Cum: 5896 tkns (73.70% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

CYRX_IN_25 [2025-03-24 10:35:07 -0400] 126 Bytes | 29 tokens | Cum: 5953 tkns (74.41% of 8k)
==========================================================================

====================================
[2025-03-24 07:35:07] # Analysis Completed
Elapsed Time: 49.31 seconds